American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2.
Jeffrey R CurtisSindhu R JohnsonDonald D AnthonyReuben J ArasaratnamLindsey R BadenAnne R BassCassandra CalabreseEllen M GravalleseRafael HarpazAndrew KrogerRebecca E SadunAmy S TurnerEleanor Anderson WilliamsTed R MikulsPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
These guidance statements, made in the context of limited clinical data, are intended to provide direction to rheumatology health care providers on how to best use COVID-19 vaccines and to facilitate implementation of vaccination strategies for RMD patients.
Keyphrases
- coronavirus disease
- healthcare
- sars cov
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- primary care
- peritoneal dialysis
- rheumatoid arthritis
- juvenile idiopathic arthritis
- prognostic factors
- electronic health record
- systemic lupus erythematosus
- respiratory syndrome coronavirus
- deep learning
- patient reported
- artificial intelligence